TY - JOUR
T1 - Forkhead Box Transcription Factors
T2 - Double-Edged Swords in Cancer
AU - Castaneda, Maria
AU - den Hollander, Petra
AU - Mani, Sendurai A.
N1 - Publisher Copyright:
©2022 The Authors
PY - 2022/6/1
Y1 - 2022/6/1
N2 - A plethora of treatment options exist for cancer therapeutics, their regulation of the epithelial–mesenchymal transition. Fork-but many are limited by side effects and either intrinsic or head factors can influence cancer development, progression, acquired resistance. The need for more effective targeted cancer metastasis, and drug resistance. In this review, we discuss the treatment has led to the focus on forkhead box (FOX) transcripvarious roles of forkhead factors in biological processes that tion factors as possible drug targets. Forkhead factors such as support cancer as well as their function as pioneering factors FOXA1 and FOXM1 are involved in hormone regulation, and their potential as targetable transcription factors in the fight immune system modulation, and disease progression through against cancer.
AB - A plethora of treatment options exist for cancer therapeutics, their regulation of the epithelial–mesenchymal transition. Fork-but many are limited by side effects and either intrinsic or head factors can influence cancer development, progression, acquired resistance. The need for more effective targeted cancer metastasis, and drug resistance. In this review, we discuss the treatment has led to the focus on forkhead box (FOX) transcripvarious roles of forkhead factors in biological processes that tion factors as possible drug targets. Forkhead factors such as support cancer as well as their function as pioneering factors FOXA1 and FOXM1 are involved in hormone regulation, and their potential as targetable transcription factors in the fight immune system modulation, and disease progression through against cancer.
UR - http://www.scopus.com/inward/record.url?scp=85131803164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131803164&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-21-3371
DO - 10.1158/0008-5472.CAN-21-3371
M3 - Review article
C2 - 35315926
AN - SCOPUS:85131803164
SN - 0008-5472
VL - 82
SP - 2057
EP - 2065
JO - Cancer Research
JF - Cancer Research
IS - 11
ER -